Navigation Links
Conference on developing new treatments for Tourette Syndrome

A conference is being organized at Washington D.C. on September 10, 11&12, by Yale School of Medicine. Several prominent scientists from Yale and other institutes will// meet to discover new ways to treat Tourette Syndrome (TS), a familial neurological disorder that begins in childhood and is characterized by chronic motor and vocal tics.

The characteristics of TS are blinking, facial movements, head jerking, throat clearing, coughing, grunting, and other brief noises. TS is not life threatening, but it can cause social isolation, particularly in children.

The chairperson of the forthcoming conference on identifying new treatments for TS, is Lawrence Scahill, professor of nursing and child psychiatry at Yale. Scientists from and outside the TS domain, will come together to discuss the latest findings in neuroscience to improvise the current treatment for tics.

"We have assembled a group of experts across a range of basic science and clinical fields who probably would not otherwise interact with each other," Scahill said. "By the end of the conference we hope to have new directions for the treatment for TS."

Over the past decade there has been a convergence of evidence from neuroimaging, neuropathology, genetics, and behavioral neuroscience about the neurobiology of TS. However, these advances have not yet had much impact on treatment. Research projects at Yale and at several other centers around the world are actively testing various treatments for TS, but new approaches are needed.

Once considered a rare and severe disorder, TS is now viewed as a disorder that ranges from mild to severe, affecting an estimated six of every 1,000 school-age children. Although many children will show a mild variant of TS, as many as one child in 1,000 in the United States may have tics that interfere with every day living.

The most effective medications are antipsychotic drugs with potent dopamine blocking pr operties. These medications, however, may be associated with sedation, weight gain, and neurological effects. Other types of medications have been used with variable results. "Clearly, it is time for recent findings from cutting edge neuroscience to inform new treatments for TS," Scahill said.

(Source: Eurekalert)
'"/>




Related medicine news :

1. International Conference On Malaria - Laveran To Genomics
2. African Conference to Combat AIDS
3. 5th European Breast Cancer Conference Talks about Everything from Patient to Oncologist
4. Consultation Conference to control HIV, TB and Malaria
5. Afghanistan Hosting A UN Funded Regional Health Conference
6. New Delhi to Host Conference on Accident & Emergency Medical Treatment
7. UN Conference Calls For Monitoring System To Check Bird Flu
8. National Autism Conference In US Expected To Draw Thousands In Attendance
9. Ayurvedic Treatment to be Focus of Conference
10. Health Ministers Conference on July 30
11. XVI International AIDS Conference To Be Held In Toronto In August
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... Peoples Health is pleased to ... on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves more ... addition to our provider network, and the addition will benefit our members in ...
(Date:1/17/2017)... ... January 17, 2017 , ... SensorInsight ... Sigfox in the U.S.A. to offer Internet of Things (IoT) solutions ... on large-scale environmental sensor deployments such as monitoring solutions used to detect potentially ...
(Date:1/17/2017)... ... January 17, 2017 , ... SC&H Group, a leading audit, tax, and consulting ... IT Advisory Services practice . Rossi is the third technology consulting leader to ... IT guidance grows, and the practice continues to expand.     , Bringing more than 25 ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... survivor Sandra Lee as keynote speaker for the 34th Annual Miami Breast Cancer ... making the announcement, PER® president, Phil Talamo, said, “We are delighted to have ...
(Date:1/17/2017)... ... , ... Many people make New Year’s resolutions or renew their commitment to better health with ... for people who want to kick off 2017 with better smiles. Dr. Mondavi is offering ... special offers include: , , A new patient package for just ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... -- In China , we say Health ... of China,s Healthy Strategy originates. 2016 ... Economic and Social Development of the People,s Republic ... state council of the People,s Republic of China ... development plan, identifying medical devices as one of the main ...
(Date:1/18/2017)... , Jan. 18, 2017 Invetech, the ... cell and advanced therapies , has announced a ... company developing "tumor starvation" treatments for acute leukemia ... Under the agreement, Invetech will develop systems to ... Erytech,s proprietary ERYCAPS technology platform, which uses a ...
(Date:1/18/2017)... Jan. 18, 2017  Tarix Orphan LLC today announced ... a Rare Pediatric Disease (RPD) designation for the company,s ... Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. There ... is limited to supportive care. "The RPD ... Designation previously granted by the FDA in this indication," ...
Breaking Medicine Technology: